Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company
creating innovative personalized therapeutics for patients with
genetically defined cancers, announced today that it will host a live
audio webcast of its discussion of the Company’s clinical programs and
pipeline at the ASH annual meeting on Monday, December 8, 2014, at 12:30
p.m. PT (3:30 p.m. ET).
The webcast will be available in the Events and Presentations section
under the Investor Relations section of the Company's website at www.epizyme.com ,
and an archived replay of the webcast will be available for 30 days
after the presentation.
for - Epizyme to Webcast Company Presentation at American Society of Hematology (ASH) Annual Meeting on December 8, 2014 investment picks